Tumor infiltrating B cells and tertiary lymphoid structures are associated with tumor response to PD-L1 blockade in NSCLC

被引：0
|
作者：
Patil, Namrata S. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-5518
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5518
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PD-L1 is highly expressed in tumor infiltrating lymphocytes in pregnancy associated breast cancer
    Blanco, L. Z., Jr.
    Pincus, J. L.
    Siziopikou, K. P.
    CANCER RESEARCH, 2017, 77
  • [32] Synergy of nanodiamond–doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells
    Hua-Zhen Xu
    Tong-Fei Li
    Chao Wang
    Yan Ma
    Yan Liu
    Mei-Yan Zheng
    Zhang-Jun-Yan Liu
    Jin-Bo Chen
    Ke Li
    Shi-Kuan Sun
    Naoki Komatsu
    Yong-Hong Xu
    Li Zhao
    Xiao Chen
    Journal of Nanobiotechnology, 19
  • [33] PD-L1 expression is associated with tumor infiltrating lymphocytes that predict response to NACT in squamous cell cervical cancer
    D'Alessandris, Nicoletta
    Palaia, Innocenza
    Pernazza, Angelina
    Tomao, Federica
    Di Pinto, Anna
    Musacchio, Lucia
    Leopizzi, Martina
    Di Maio, Valeria
    Pecorella, Irene
    Benedetti Panici, Pierluigi
    Della Rocca, Carlo
    VIRCHOWS ARCHIV, 2021, 478 (03) : 517 - 525
  • [34] Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells
    Tu, Jingyao
    Xu, Haoran
    Ma, Li
    Li, Chunya
    Qin, Wan
    Chen, Xinyi
    Yi, Ming
    Sun, Li
    Liu, Bo
    Yuan, Xianglin
    THERANOSTICS, 2022, 12 (02): : 747 - 766
  • [35] PD-L1 expression is associated with tumor infiltrating lymphocytes that predict response to NACT in squamous cell cervical cancer
    Nicoletta D’Alessandris
    Innocenza Palaia
    Angelina Pernazza
    Federica Tomao
    Anna Di Pinto
    Lucia Musacchio
    Martina Leopizzi
    Valeria Di Maio
    Irene Pecorella
    Pierluigi Benedetti Panici
    Carlo Della Rocca
    Virchows Archiv, 2021, 478 : 517 - 525
  • [36] The efficacy of PD-L1 blockade on PD-L1 negative medulloblastoma is dependent on timing and the tumor microenvironment
    Allen, Frederick
    Dorand, Rodney Dixon
    Rauhe, Peter
    Petrosiute, Agne
    Huang, Alex Y.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [37] Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
    Fei Tang
    Pan Zheng
    Cell & Bioscience, 8
  • [38] Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
    Tang, Fei
    Zheng, Pan
    CELL AND BIOSCIENCE, 2018, 8
  • [39] PD-L1 Blockade Improves the Efficacy of Adoptively Transferred Tumor Infiltrating Lymphocytes in a Colon Carcinoma Model
    Kodumudi, Krithika N.
    Mackay, Amy
    Seigel, Jessica
    Robinson, John
    Pilon-Thomas, Shari
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 750 - 750
  • [40] Identifying gut microbial signatures associated with B cells and tertiary lymphoid structures (TLS) in the tumor microenvironment (TME) in response to immune checkpoint blockade (ICB)
    Nassif, Elise F.
    Chelvanambi, Manoj
    Chen, Lili
    Wu, Chia-Chin
    Damania, Ashish
    Keung, Emily Zhi-Yun
    Witt, Russell G.
    White, Michael
    Ajami, Nadim J.
    Wong, Matthew C.
    Somaiah, Neeta
    Sepesi, Boris
    Basu, Sreyashi
    Allison, James Patrick
    Sharma, Padmanee
    McBride, Kevin
    Fridman, Wolf-Herve
    Wargo, Jennifer Ann
    Cascone, Tina
    Roland, Christina Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345